Cargando…
Altered T cell phenotypes associated with clinical relapse of multiple sclerosis patients receiving fingolimod therapy
Multiple sclerosis (MS) is a T cell-mediated autoimmune disease. Fingolimod, a highly effective disease-modifying drug for MS, retains CCR7(+) central memory T cells in which autoaggressive T cells putatively exist, in secondary lymphoid organs, although relapse may still occur in some patients. Her...
Autores principales: | Fujii, Chihiro, Kondo, Takayuki, Ochi, Hirofumi, Okada, Yoichiro, Hashi, Yuichiro, Adachi, Tetsuya, Shin-Ya, Masaharu, Matsumoto, Sadayuki, Takahashi, Ryosuke, Nakagawa, Masanori, Mizuno, Toshiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082790/ https://www.ncbi.nlm.nih.gov/pubmed/27752051 http://dx.doi.org/10.1038/srep35314 |
Ejemplares similares
-
Immune Skew of Circulating Follicular Helper T Cells Associates With Myasthenia Gravis Severity
por: Ashida, Shinji, et al.
Publicado: (2021) -
Radiological and Laboratory Features of Multiple Sclerosis Patients With Immunosuppressive Therapy: A Multicenter Retrospective Study in Japan
por: Ashida, Shinji, et al.
Publicado: (2021) -
Association of cerebrospinal inflammatory profile with radiological features in newly diagnosed treatment-naïve patients with multiple sclerosis
por: Ashida, Shinji, et al.
Publicado: (2022) -
Disease reactivation in a patient with secondary progressive multiple sclerosis after switching treatment from fingolimod to siponimod
por: Senzaki, Kensuke, et al.
Publicado: (2021) -
Multiple Sclerosis Relapses Following Cessation of Fingolimod
por: Malpas, Charles B., et al.
Publicado: (2022)